Here's the live share price of Epigral along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Epigral has gained 34.31% CAGR. Over the past year, the corresponding return has been -4.19%.
Epigral’s current P/E of 17.74x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Epigral | -1.31 | -4.97 | -3.34 | -0.08 | -4.19 | 5.37 | 34.31 |
PI Industries | -1.31 | -3.94 | -6.00 | 13.69 | -19.87 | 4.52 | 14.42 |
UPL | -1.07 | 1.38 | 10.09 | 14.34 | 21.21 | -0.40 | 8.19 |
Sumitomo Chemical India | -0.65 | -2.69 | 9.37 | 15.57 | 6.68 | 4.21 | 16.56 |
Bayer Cropscience | -1.26 | -8.83 | -6.53 | 4.17 | -18.37 | -0.66 | -1.98 |
Atul | -0.30 | -4.19 | -14.88 | 11.77 | -20.21 | -11.72 | 0.39 |
Sharda Cropchem | -13.78 | -9.94 | 12.81 | 60.18 | 57.30 | 19.57 | 28.13 |
Dhanuka Agritech | -5.08 | -4.91 | -7.73 | 38.86 | -1.75 | 29.10 | 16.96 |
Rallis India | -2.90 | -3.55 | 7.65 | 61.65 | 3.20 | 15.45 | 3.64 |
NACL Industries | -7.65 | -9.86 | 50.72 | 287.71 | 361.16 | 47.57 | 44.83 |
Bharat Rasayan | -0.77 | -11.46 | 12.75 | -3.53 | -25.98 | -6.05 | 2.41 |
Bhagiradha Chemicals & Industries | -3.01 | -6.34 | -13.20 | -11.95 | -31.94 | 25.54 | 55.86 |
India Pesticides | -0.02 | -7.48 | -0.12 | 57.39 | -1.78 | -8.53 | -9.18 |
Insecticides (India) | -4.43 | -19.69 | -7.54 | 36.37 | -17.55 | 5.90 | 20.35 |
Meghmani Organics | -1.93 | -6.62 | -11.90 | 21.14 | -23.83 | -14.42 | -3.04 |
Astec Lifesciences | 0.98 | 8.50 | 7.06 | 21.19 | -28.07 | -23.23 | -5.42 |
Excel Industries | -5.17 | -7.17 | -5.53 | 24.42 | -24.36 | -6.76 | 6.38 |
Punjab Chemicals and Crop Protection | -6.43 | -16.46 | -0.38 | 27.62 | -12.86 | -6.96 | 13.29 |
Heranba Industries | -5.12 | -0.11 | 16.00 | 46.71 | -32.27 | -16.75 | -16.45 |
3B BlackBio Dx | -0.35 | -7.12 | -12.34 | -23.28 | 0.39 | 56.92 | 33.52 |
Over the last one year, Epigral has declined 4.19% compared to peers like PI Industries (-19.87%), UPL (21.21%), Sumitomo Chemical India (6.68%). From a 5 year perspective, Epigral has outperformed peers relative to PI Industries (14.42%) and UPL (8.19%).
Day | SMA | EMA |
---|---|---|
5 | 1,798.37 | 1,783.33 |
10 | 1,816.35 | 1,802.37 |
20 | 1,838.03 | 1,822.83 |
50 | 1,833.75 | 1,830.9 |
100 | 1,827.34 | 1,830.45 |
200 | 1,845.3 | 1,808.09 |
In the latest quarter, Epigral saw a drop in promoter holding to 68.83%, while DII stake increased to 4.78%, FII holding rose to 3.06%, and public shareholding moved down to 23.30% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
HSBC Value Fund | 4,67,151 | 0.68 | 94.33 |
Bandhan Small Cap Fund | 3,33,007 | 0.48 | 67.24 |
HSBC Focused Fund | 2,50,650 | 3 | 50.61 |
HSBC Flexi Cap Fund | 2,13,965 | 0.85 | 43.2 |
HSBC ELSS Tax saver Fund | 1,21,645 | 0.59 | 24.56 |
HSBC Business Cycles Fund | 76,350 | 1.37 | 15.42 |
HSBC Tax Saver Equity Fund | 17,300 | 1.4 | 3.49 |
Date Time | Announcement |
---|---|
Sep 03, 2025, 11:17 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) |
Aug 28, 2025, 11:17 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Aug 20, 2025, 12:16 AM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Aug 19, 2025, 3:40 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Aug 06, 2025, 9:55 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Epigral Ltd. is a Public Limited Listed company incorporated on 11/09/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2007PLC051717 and registration number is 051717. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 2550.13 Cr. and Equity Capital is Rs. 43.14 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Epigral is ₹1,773.20 as on Sep 09, 2025.
The Epigral is operating in the Chemicals Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Epigral is ₹7,649.82 Cr as on Sep 09, 2025.
Today’s highest and lowest price of Epigral are ₹1,803.80 and ₹1,755.25.
The 52-week high/low is the highest and lowest price at which Epigral stock has traded in the past 52-week or nearly a year. The 52-week high of Epigral is ₹2,408.35 and 52-week low of Epigral is ₹1,506.60 as on Sep 09, 2025.
The Epigral has shown returns of 0.49% over the past day, -4.97% for the past month, -3.34% over 3 months, -4.19% over 1 year, 5.37% across 3 years, and 34.31% over 5 years.
P/E ratio of and PB ratio of Epigral are 17.74 and 4.02 on Sep 09, 2025. While the company gives a dividend yield of 0.34 per annum.